Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2015

Open Access 01-02-2015 | Research Article

Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society

Authors: Aleksandra Drozdowska, Tomasz Hermanowski

Published in: International Journal of Clinical Pharmacy | Issue 1/2015

Login to get access

Abstract

Background Generics have the potential to contain drug therapy costs; successful implementation of generic substitution policy largely depends on consumers’ willingness to choose generics. Objective This study aims to analyse the opinions, experiences and preferences of Polish patients towards generic medicines. Setting The study was performed in Poland. Method The survey was conducted in June 2013 by means of face-to-face interviews. Respondents were drawn from the general population according to a population structure. The study covered a representative sample of 1,000 Poles; the results can be generalized to apply to the Polish population at large. Results Fifty-two percent of respondents declared to be more often choosing generics, twenty-three percent did not have any specific preferences, and twenty-five percent were more willing to choose brand-name medicines. Past experience with cheaper generic medicines, secondary or lower education, low income and residence in specific regions of Poland were all significantly associated with an increased willingness to choose generics. Respondents’ attitudes towards generics were mostly influenced by the opinions of doctors and pharmacists. According to respondents, attitudes towards generics among doctors, pharmacists, family and friends, and in the mass media were mostly positive. There was no relationship between the preference of respondents for generics and factors such as their age, life stage, gender, household size or urban/rural locality. As a result of substituting a brand-name drug with its generic equivalent, 72 % of respondents reported that they had not noticed any difference in drug effectiveness; 21 % had experienced a reduced effectiveness of treatment or increased side effects at least once; and 7 % claimed the generic worked better. The majority of respondents who used cheaper substitutes claimed that generics represented good or very good quality. Conclusion The study demonstrates that, when choosing medicines, Poles rely mainly on the opinions of their doctors and pharmacists. Therefore, it is recommended that: (1) the option of using generics be promoted when writing prescriptions, and (2) the obligation on pharmacists to inform customers of their option to purchase generics be enforced.
Literature
4.
go back to reference McManus P, Birkett DJ, Dudley J, Stevens A. Impact of the minimum pricing policy and introduction of brand (generic) substitution into the pharmaceutical benefits scheme in Australia. Pharmacoepidemiol Drug Saf. 2001;10(4):295–300.PubMedCrossRef McManus P, Birkett DJ, Dudley J, Stevens A. Impact of the minimum pricing policy and introduction of brand (generic) substitution into the pharmaceutical benefits scheme in Australia. Pharmacoepidemiol Drug Saf. 2001;10(4):295–300.PubMedCrossRef
5.
go back to reference Gossell-Williams M. Generic substitution: a 2005 survey of the acceptance and perceptions of physicians in Jamaica. West Indian Med J. 2007;56(5):458–63.PubMed Gossell-Williams M. Generic substitution: a 2005 survey of the acceptance and perceptions of physicians in Jamaica. West Indian Med J. 2007;56(5):458–63.PubMed
6.
go back to reference Homedes N, Ugalde A. Multisource drug policies in Latin America: survey of 10 countries. Bull World Health Organ. 2005;83(1):64–70.PubMedCentralPubMed Homedes N, Ugalde A. Multisource drug policies in Latin America: survey of 10 countries. Bull World Health Organ. 2005;83(1):64–70.PubMedCentralPubMed
8.
go back to reference Ustawa o refundacji leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych 2011 [Reimbursement of Medicines, Foodstuffs Intended for Particular Nutritional Uses and Medical Devices Act of 2011]. J Laws 2011; No. 122, item 696, art. 44 ust. 2 (May 12 2011). Ustawa o refundacji leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych 2011 [Reimbursement of Medicines, Foodstuffs Intended for Particular Nutritional Uses and Medical Devices Act of 2011]. J Laws 2011; No. 122, item 696, art. 44 ust. 2 (May 12 2011).
9.
go back to reference Kjøenniksen I, Lindbaek M, Granås AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28:284–9.PubMedCrossRef Kjøenniksen I, Lindbaek M, Granås AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28:284–9.PubMedCrossRef
10.
go back to reference Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen RD, Kochen MM, Gleiter CH, Hummers-Pradier E. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther. 2005;43(10):472–9.PubMedCrossRef Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen RD, Kochen MM, Gleiter CH, Hummers-Pradier E. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther. 2005;43(10):472–9.PubMedCrossRef
11.
go back to reference Håkonsen H, Eilertsen M, Borge H, Borge H, Toverud EL. Generic substitution: additional challenge for adherence in hypertensive patients? Curr Med Res Opin. 2009;25:2515–21.PubMedCrossRef Håkonsen H, Eilertsen M, Borge H, Borge H, Toverud EL. Generic substitution: additional challenge for adherence in hypertensive patients? Curr Med Res Opin. 2009;25:2515–21.PubMedCrossRef
12.
go back to reference Al-Gedadi NA, Hassali MA, Shafie AA. A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang. Malays Pharm Pract. 2008;6:93–5. Al-Gedadi NA, Hassali MA, Shafie AA. A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang. Malays Pharm Pract. 2008;6:93–5.
13.
go back to reference Gleiter CH, Gundert-Remy U. Bioinequivalence and drug toxicity. How great is the problem and what can be done? Drug Saf. 1994;11:1–6.PubMedCrossRef Gleiter CH, Gundert-Remy U. Bioinequivalence and drug toxicity. How great is the problem and what can be done? Drug Saf. 1994;11:1–6.PubMedCrossRef
14.
go back to reference Meredith PA. Generic drugs. therapeutic equivalence. Drug Saf. 1996;4:233–42.CrossRef Meredith PA. Generic drugs. therapeutic equivalence. Drug Saf. 1996;4:233–42.CrossRef
15.
go back to reference Barsky AJ, Saintfort R, Rogers MP, Borus JF. Non-specific medication side effects and the nocebo phenomenon. JAMA. 2002;287:622–7.PubMedCrossRef Barsky AJ, Saintfort R, Rogers MP, Borus JF. Non-specific medication side effects and the nocebo phenomenon. JAMA. 2002;287:622–7.PubMedCrossRef
17.
go back to reference Banahan BF, Kolassa EM. A physician survey on generic drugs and substitution of critical dose medications. Arch Intern Med. 1997;157(18):2080–8.PubMedCrossRef Banahan BF, Kolassa EM. A physician survey on generic drugs and substitution of critical dose medications. Arch Intern Med. 1997;157(18):2080–8.PubMedCrossRef
18.
go back to reference Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc (Wash). 2000;40(3):378–83. Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc (Wash). 2000;40(3):378–83.
19.
go back to reference Mott DA, Cline RR. Exploring generic drug use behaviour: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care. 2002;40(8):662–74.PubMedCrossRef Mott DA, Cline RR. Exploring generic drug use behaviour: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care. 2002;40(8):662–74.PubMedCrossRef
20.
go back to reference Suh DC. Trends of generic substitution in community pharmacies. Pharm World Sci. 1999;21(6):260–5.PubMedCrossRef Suh DC. Trends of generic substitution in community pharmacies. Pharm World Sci. 1999;21(6):260–5.PubMedCrossRef
21.
go back to reference Kobayashi E, Karigome H, Sakurada T, Satoh N, Ueda S. Patients’ attitudes towards generic drug substitution in Japan. Health Policy. 2011;99:60–5.PubMedCrossRef Kobayashi E, Karigome H, Sakurada T, Satoh N, Ueda S. Patients’ attitudes towards generic drug substitution in Japan. Health Policy. 2011;99:60–5.PubMedCrossRef
22.
go back to reference Shrank WH, Cadarette SM, Cox E, Fischer MA, Mehta J, Brookhart AM, Avorn J, Choudhry NK. Is there a relationship between patient beliefs or communication about generic drugs and medication utilization? Med Care. 2009;47:319–25.PubMedCentralPubMedCrossRef Shrank WH, Cadarette SM, Cox E, Fischer MA, Mehta J, Brookhart AM, Avorn J, Choudhry NK. Is there a relationship between patient beliefs or communication about generic drugs and medication utilization? Med Care. 2009;47:319–25.PubMedCentralPubMedCrossRef
23.
go back to reference Vallès JA, Barreiro M, Cereza G, Ferro JJ, Martínez MJ, Escribà JM, Iglesias B, Cucurull E, Barceló E. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy. 2003;65:269–75.PubMedCrossRef Vallès JA, Barreiro M, Cereza G, Ferro JJ, Martínez MJ, Escribà JM, Iglesias B, Cucurull E, Barceló E. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy. 2003;65:269–75.PubMedCrossRef
24.
go back to reference Heikkilä R, Mäntyselkä P, Hartikainen-Herranen K, Ahonen R. Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland. Health Policy. 2007;82(3):366–74.PubMedCrossRef Heikkilä R, Mäntyselkä P, Hartikainen-Herranen K, Ahonen R. Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland. Health Policy. 2007;82(3):366–74.PubMedCrossRef
25.
go back to reference Iosifescu A, Halm EA, McGinn T, Siu AL, Federman AD. Beliefs about generic drugs among elderly adults in hospital-based primary care practices. Patient Educ Couns. 2008;73(2):377–83.PubMedCentralPubMedCrossRef Iosifescu A, Halm EA, McGinn T, Siu AL, Federman AD. Beliefs about generic drugs among elderly adults in hospital-based primary care practices. Patient Educ Couns. 2008;73(2):377–83.PubMedCentralPubMedCrossRef
26.
go back to reference Håkonsen H, Toverud EL. A review of patient perspectives on generics substitution: what are the challenges for optimal drug use. Generics Biosimilars Init J (GaBI J). 2012;1(1):28–32.CrossRef Håkonsen H, Toverud EL. A review of patient perspectives on generics substitution: what are the challenges for optimal drug use. Generics Biosimilars Init J (GaBI J). 2012;1(1):28–32.CrossRef
Metadata
Title
Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society
Authors
Aleksandra Drozdowska
Tomasz Hermanowski
Publication date
01-02-2015
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 1/2015
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-014-0041-8

Other articles of this Issue 1/2015

International Journal of Clinical Pharmacy 1/2015 Go to the issue